News
Thermo Fisher Scientific Completes Sale
Mar 28 2014
Thermo Fisher Scientific a world leader in serving science, has completed the sale of its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare, a unit of General Electric Company (NYSE: GE), for $1.065 billion.
The businesses will become part of GE Healthcare’s Life Sciences division. The combined revenue of the three businesses was $250 million in 2013. Thermo Fisher committed to sell these businesses to address regulatory concerns related to its acquisition of Life Technologies Corporation, which was completed on February 3, 2014.
Digital Edition
Lab Asia Dec 2025
December 2025
Chromatography Articles- Cutting-edge sample preparation tools help laboratories to stay ahead of the curveMass Spectrometry & Spectroscopy Articles- Unlocking the complexity of metabolomics: Pushi...
View all digital editions
Events
Jan 21 2026 Tokyo, Japan
Jan 28 2026 Tokyo, Japan
Jan 29 2026 New Delhi, India
Feb 07 2026 Boston, MA, USA
Asia Pharma Expo/Asia Lab Expo
Feb 12 2026 Dhaka, Bangladesh



